Premier Clinical Trials Services

A unique opportunity to acquire a well-established and reputable provider of clinical trials services, specialising in randomisation solutions for the clinical trials industry. With over 20 years of operation, this business stands as Australia’s only local independent provider, offering a suite of secure, integrated, and fully validated solutions.

Services Offered
Patient Randomisation: Advanced Web solutions.
Drug Supply Management: Efficient handling and distribution.
Patient Diaries: Comprehensive monitoring tools.
Payment Management: Streamlined financial solutions for clinical trials.

Key Highlights
Proven Track Record: Successfully serving the industry for two decades.
Exclusive Provider: The sole independent local provider in Australia with proprietary technology.
Global Reach: Potential to expand services globally with minimal marketing efforts.
Strong Industry Position: Essential role within the Clinical Research industry, which supports the global pharmaceutical sector.

Growth Opportunities Despite its established market presence, there is significant potential for expansion, particularly in international markets. The current business growth has been driven purely by word-of-mouth, indicating a robust opportunity for growth through strategic marketing and business development efforts.

This business would serve as an excellent strategic addition for an existing scientific data management company looking to expand its service offerings or as a remarkable entry-point for professionals or entities active in the clinical research industry.

The owners are inviting offers over $150,000 from suitably qualified individuals or businesses interested in acquiring a reputable and solidly established service provider in the clinical trials sector.

Interested parties are encouraged to express their interest promptly, as this opportunity combines established operations with significant growth potential in a critical industry sector.

Take the next step in your professional journey with this pivotal business acquisition.